Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fuse

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Hematology|June 1, 1996
Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiencyI Fuse, T Ootsuka, A Hattori, et al.
Acta Haematologica|April 29, 1998
Overproduction of antiplatelet antibody against glycoprotein IIb after splenectomy in a patient with Evans syndrome resulting in acquired thrombastheniaI Fuse, W Higuchi, M Narita, et al.
The Journal of Clinical Investigation|October 1, 1994
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorderT Hirata, A Kakizuka, F Ushikubi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1995
[Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis]Y Uesugi, K Toba, K Nikkuni, et al.
Thrombosis and Haemostasis|December 1, 1996
Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activityI Fuse, A Hattori, M Mito, et al.
European Journal of Haematology|May 5, 1999
Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell linesY Uesugi, I Fuse, K Toba, et al.
Leukemia|March 1, 1995
5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?T Koike, Y Uesugi, K Toba, et al.
Bone Marrow Transplantation|December 2, 2008
Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractionsJ Tsuchiyama, T Yoshino, T Saito, et al.
Blood|February 15, 1993
Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activationI Fuse, M Mito, A Hattori, et al.
Leukemia & Lymphoma|July 27, 2016
Primary Thrombocythemia in Japan: A Survey of 225 PatientsA Hattori, R Nagayama, K Kishi, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Hematology|June 1, 1996
Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiencyI Fuse, T Ootsuka, A Hattori, et al.
Acta Haematologica|April 29, 1998
Overproduction of antiplatelet antibody against glycoprotein IIb after splenectomy in a patient with Evans syndrome resulting in acquired thrombastheniaI Fuse, W Higuchi, M Narita, et al.
The Journal of Clinical Investigation|October 1, 1994
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorderT Hirata, A Kakizuka, F Ushikubi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1995
[Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis]Y Uesugi, K Toba, K Nikkuni, et al.
Thrombosis and Haemostasis|December 1, 1996
Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activityI Fuse, A Hattori, M Mito, et al.
European Journal of Haematology|May 5, 1999
Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell linesY Uesugi, I Fuse, K Toba, et al.
Leukemia|March 1, 1995
5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?T Koike, Y Uesugi, K Toba, et al.
Bone Marrow Transplantation|December 2, 2008
Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractionsJ Tsuchiyama, T Yoshino, T Saito, et al.
Blood|February 15, 1993
Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activationI Fuse, M Mito, A Hattori, et al.
Leukemia & Lymphoma|July 27, 2016
Primary Thrombocythemia in Japan: A Survey of 225 PatientsA Hattori, R Nagayama, K Kishi, et al.
Pageof 7